Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Turning Foes To Friends: Targeting Cancer-associated Fibroblasts

Xueman Chen, Erwei Song
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance. Among all the stromal cells that populate the tumour microenvironment, cancer-associated fibroblasts (CAFs) are the most abundant and are critically involved in cancer progression. CAFs regulate the biology of tumour cells and other stromal cells via cell–cell contact, releasing numerous regulatory factors and synthesizing and remodelling the extracellular matrix, and thus these cells affect cancer initiation and development. The recent characterization of CAFs based on specific cell surface markers not only deepens our insight into their phenotypic heterogeneity and functional diversity but also brings CAF-targeting therapies for cancer treatment onto the agenda. In this Review, we discuss the current knowledge of biological hallmarks, cellular origins, phenotypical plasticity and functional heterogeneity of CAFs and underscore their contribution to cancer progression. Moreover, we highlight relevant translational advances and potential therapeutic strategies that target CAFs for cancer treatment.Cancer-associated fibroblasts (CAFs) are often the most abundant cell type in the tumour microenvironment. Here, Song and colleagues discuss how to target or harness these cells for cancer therapy. They highlight the progress made to date and the remaining challenges in bringing CAF-targeted therapies to the clinic.
This paper references
10.1158/0008-5472.CAN-12-0954
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
R. Patel (2012)
10.1158/0008-5472.CAN-15-2973
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Xuguang Yang (2016)
10.1002/hep.20853
Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line
X. Wang (2005)
10.5694/j.1326-5377.1993.tb141344.x
A population based study
P. McIntyre (1993)
10.1016/j.cell.2014.05.045
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Ruth Scherz-Shouval (2014)
indirect pharmacological targeting of pancreatic cancerassociated fibroblasts
Moatassim Billah (2016)
10.1073/pnas.1419554111
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
Twana Alkasalias (2014)
10.1016/S0140-6736(12)60644-8
Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
R. Kirsner (2012)
This is one of the two earliest back-to-back reports demonstrating the suppressive effects of tumour stroma on cancer progression
10.1016/j.cell.2013.07.036
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
X. Zhang (2013)
10.1200/JCO.2013.49.9525
Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.
Daniel J Kim (2014)
10.1158/0008-5472.CAN-14-3041
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.
A. Lo (2015)
10.15252/emmm.201404346
Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
Camille Duluc (2015)
10.1016/j.ccr.2011.02.006
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
J. Chen (2011)
10.1016/j.cell.2007.10.054
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
F. Yu (2007)
10.1038/bjc.2013.768
Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Y. Yu (2014)
Fibroblast heterogeneity in the cancer
D. Ohlund (2014)
an open label, doseescalation, phase 1 trial
Younes (2016)
Mechanotransduction and YAPdependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts
F Calvo (2013)
10.1152/PHYSREV.00046.2003
Role of caveolae and caveolins in health and disease.
A. Cohen (2004)
10.1158/0008-5472.CAN-16-0866
Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
L. Miao (2017)
connecting TGF beta signaling with “Warburg-like” cancer metabolism and L lactate production
Guido (2012)
10.1136/gutjnl-2012-302529
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
M. A. Jacobetz (2012)
10.1038/cr.2017.34
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Shicheng Su (2017)
10.1172/JCI26532
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.
M. Loeffler (2006)
10.1016/j.immuni.2011.03.005
Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation.
I. Gutcher (2011)
10.1038/nri2808
The polarization of immune cells in the tumour environment by TGFβ
R. Flavell (2010)
10.1038/nrc745
New functions for the matrix metalloproteinases in cancer progression
M. Egeblad (2002)
therapeutic translation for fibrotic disease
T. A. Wynn (2012)
10.1016/S1470-2045(15)00584-7
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial.
A. Younes (2016)
importance of the stromal reaction
L. Ronnov Jessen (1996)
10.1038/nrc1877
Fibroblasts in cancer
R. Kalluri (2006)
10.1016/j.ccell.2015.11.002
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.
B. Özdemir (2015)
10.1038/onc.2012.270
p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
M. M. Al-Ansari (2013)
10.1126/scitranslmed.aac5272
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
David Hong (2015)
10.3322/caac.21262
Global cancer statistics, 2012
L. Torre (2015)
10.1016/j.ccr.2011.01.020
Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.
M. Quante (2011)
10.1016/j.semcancer.2014.02.006
Prognostic relevance of cancer-associated fibroblasts in human cancer.
Janna Paulsson (2014)
10.1016/j.cell.2005.02.034
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
A. Orimo (2005)
10.1182/BLOOD.V73.3.625.625
The common acute lymphoblastic leukemia antigen (CD10)--emancipation from a functional enigma.
T. Lebien (1989)
10.1158/0008-5472.CAN-16-1615
Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
L. Zhao (2017)
10.1038/s41467-017-00985-8
Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane
Alexandros Glentis (2017)
10.3410/f.6123957.6395055
Faculty Opinions recommendation of Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.
D. Kranz (2010)
10.1016/j.cell.2018.01.028
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
J. Huelsken (2018)
10.1172/JCI30082
The pancreatic stellate cell: a star on the rise in pancreatic diseases.
M. Omary (2007)
10.1038/nature11183
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Ravid Straussman (2012)
10.1038/nm.2848
Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury
S. Dulauroy (2012)
10.1053/j.gastro.2011.06.047
Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Fieke E. M. Froeling (2011)
Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases.
Odile Picard (1986)
10.1084/jem.20162024
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
D. Öhlund (2017)
10.1038/ncomms3516
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan (2013)
10.1038/nm.4099
Regulation of pancreatic cancer aggressiveness by stromal stiffening
N. Rath (2016)
10.1097/00000441-186104000-00025
Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre
R. Virchow (1861)
Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
F. Moinfar (2000)
10.1002/pros.20927
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients
P. Wikström (2009)
10.1016/j.ccr.2012.08.013
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
A. Calon (2012)
10.1038/s41467-018-03347-0
Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
M. Lakins (2018)
10.1136/gutjnl-2015-310977
Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
Gemma Ferrer-Mayorga (2016)
Carcinoma associated fibroblastlike differentiation of human mesenchymal stem cells
Mishra (2008)
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
A. Scott (2003)
Targeting fibroblast activation protein inhibits tumor www.nature.com/nrd R e v i e w s 114 | FeBRuARY 2019 | volume 18 stromagenesis and growth in mice
A. M. Santos (2009)
10.1016/j.ccr.2011.06.018
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma.
V. Sanz-Moreno (2011)
10.1073/pnas.1017547108
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Christoph H. Österreicher (2010)
10.1200/JCO.2015.61.4578
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
H. Hurwitz (2015)
& Aboussekhra, A. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts
M M Al-Ansari (2013)
10.3322/caac.20107
Global cancer statistics
A. Jemal (2011)
10.1002/emmm.201000073
Oxidative stress promotes myofibroblast differentiation and tumour spreading
A. Toullec (2010)
10.1126/science.1171362
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
K. Olive (2009)
10.1158/2326-6066.CIR-13-0150
Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1
J. N. Arnold (2013)
10.1016/j.stem.2017.12.009
Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
Takashi Seino (2018)
10.1038/nrc.2017.51
Microenvironmental regulation of tumour angiogenesis
M. Palma (2017)
10.1007/s004280100530
CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions
P. Barth (2001)
10.1038/onc.2016.60
Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion
T. T. Vellinga (2016)
This is the first report on the role of stromal cells in remodelling the pre-metastatic soil
10.1002/path.4769
Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
O. Hashimoto (2016)
10.1158/1078-0432.CCR-06-2191
Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
T. Tsujino (2007)
10.1038/s41467-017-02583-0
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
Tian Fang (2017)
10.1158/0008-5472.CAN-07-5714
Cancer-associated stromal fibroblasts promote pancreatic tumor progression.
R. Hwang (2008)
10.1002/path.4034
Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts
S. Simpkins (2012)
10.1186/1741-7015-6-11
Collagen density promotes mammary tumor initiation and progression
P. Provenzano (2008)
10.1186/bcr2222
Gene expression profiling of the tumor microenvironment during breast cancer progression
X. Ma (2008)
10.1038/nrc1477
Friends or foes — bipolar effects of the tumour stroma in cancer
M. Mueller (2004)
10.1084/jem.20122344
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
E. W. Roberts (2013)
10.1158/0008-5472.CAN-07-3127
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.
E. Zeisberg (2007)
10.1158/1078-0432.CCR-16-1516
Structure and Function of a Prostate Cancer Dissemination–Permissive Extracellular Matrix
M. Penet (2016)
10.1016/j.semcancer.2009.05.003
The angiogenic switch in carcinogenesis.
Vanessa Baeriswyl (2009)
10.1158/0008-5472.CAN-10-0673
Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations.
A. N. Hosein (2010)
CD10(+)GPR77(+) cancerassociated fibroblasts promote cancer formation and chemoresistance by sustaining cancer
S Su (2018)
implications for tumorigenesis
Moinfar (2000)
10.1038/nrc.2017.69
Classifying the evolutionary and ecological features of neoplasms
C. Maley (2017)
potential biomarker for hepatocellular carcinoma
Ma (2017)
Tumorpromoting desmoplasia is disrupted by depleting FAPexpressing stromal cells
A Lo (2015)
10.1038/nature16064
EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
X. Zheng (2015)
10.1038/nrc.2016.73
The biology and function of fibroblasts in cancer
R. Kalluri (2016)
10.1007/s00109-013-1020-6
Exosomes in tumor microenvironment influence cancer progression and metastasis
C. Kahlert (2013)
10.1038/nature08486
Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors
A. Trimboli (2009)
10.1056/NEJMOA071825
Breast-cancer stromal cells with TP53 mutations and nodal metastases.
A. Patócs (2007)
CD10GPR77 Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su (2018)
10.1172/JCI38988
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
A. M. Santos (2009)
10.2174/1381612043384808
Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis.
C. Ebbinghaus (2004)
10.1158/0008-5472.CAN-12-3022
Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens.
J. Zhang (2013)
10.1055/S-0037-1613457
Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
J. Martens (2003)
10.1152/PHYSREV.1996.76.1.69
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.
L. Rønnov-Jessen (1996)
10.1073/PNAS.0401064101
Reconstruction of functionally normal and malignant human breast tissues in mice.
C. Kuperwasser (2004)
10.1073/pnas.1300415110
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
A. Neesse (2013)
10.4161/cc.21384
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production
Carmela Guido (2012)
10.1160/TH05-01-0054
Plasminogen activation and cancer.
K. Danø (2005)
Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumorpromoting inflammation in an NF κB-dependent manner
N. Erez (2010)
an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer
Hofheinz (2003)
10.1038/onc.2016.353
CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS
Katherine Richards (2017)
10.1002/ijc.29831
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice
Jinxu Fang (2016)
10.1073/pnas.1013805107
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
Yasushi Kojima (2010)
Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.
M. Shekhar (2001)
10.1016/j.cell.2011.02.013
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
10.3322/canjclin.49.1.33
Global cancer statistics
D. Parkin (1999)
10.1016/j.cell.2018.01.009
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su (2018)
10.1158/1078-0432.CCR-15-2851
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
H. Brechbuhl (2016)
10.1038/ncb1658
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells
C. Gaggioli (2007)
10.1038/nm.2807
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
T. Wynn (2012)
10.1038/nrm3904
Remodelling the extracellular matrix in development and disease
C. Bonnans (2014)
10.1158/1078-0432.CCR-17-2033
Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice
Elizabeth K Duperret (2018)
10.4161/cc.8.4.7669
Origin of carcinoma associated fibroblasts
I. Haviv (2009)
10.1074/jbc.C500287200
An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2*
N. Gerard (2005)
10.1158/0008-5472.CAN-16-2129
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.
P. Sansone (2017)
10.1073/pnas.0909797107
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers
A. Saadi (2010)
10.1158/1078-0432.CCR-07-4453
Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding
B. Belletti (2008)
10.1084/jem.20140692
Fibroblast heterogeneity in the cancer wound
D. Öhlund (2014)
Human cancerassociated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death
Cheteh (2017)
at the crossroads of development and tumor metastasis
J. Yang (2008)
10.1016/j.celrep.2016.04.019
Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
E. Y. T. Lau (2016)
10.1016/j.semcancer.2010.04.004
Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors.
E. Cukierman (2010)
10.1016/S1470-2045(16)30067-5
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
M. C. van Maaren (2016)
10.1016/S0140-6736(15)01238-6
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
G. Zalcman (2016)
10.1038/nrd4390
Is there new hope for therapeutic matrix metalloproteinase inhibition?
R. Vandenbroucke (2014)
10.1158/1078-0432.CCR-15-2010
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer
S. Hingorani (2016)
10.1158/0008-5472.CAN-13-2740
Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Martin Augsten (2014)
10.1016/S0272-6386(12)80352-0
Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis.
H. P. Rodemann (1991)
10.1158/0008-5472.CAN-04-4510
Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.
B. Grum-Schwensen (2005)
This is one of the two earliest back-to-back reports on the tumour-suppressive role of CAFs in cancer progression, along with reference 14
10.1016/S0140-6736(00)49915-0
The distribution of secondary growths in cancer of the breast. 1889.
S. Paget (1989)
a phase 2, multicentre, double blind, randomised, placebocontrolled trial
Kirsner (2012)
10.1038/nrd.2016.193
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Y. Shi (2017)
10.1038/ncomms2766
Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis
Y. Jung (2013)
10.1038/nrm809
Myofibroblasts and mechano-regulation of connective tissue remodelling
J. Tomasek (2002)
10.1016/j.bbrc.2012.05.081
The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
J. H. Kim (2012)
10.1002/path.4727
Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
Elisabete F. Carapuça (2016)
10.1136/gutjnl-2016-311954
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E. Hessmann (2017)
10.1053/j.gastro.2013.07.025
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Abasi E Ene-Obong (2013)
10.1111/j.1582-4934.2007.00213.x
The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine
B. Eyden (2008)
This study presents the first demonstration that mechanical coupling between CAFs and cancer cells underlies collective cancer cell metastasis
A Labernadie (2017)
10.1038/cddis.2014.263
The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression
Q. Zhu (2014)
10.1073/pnas.1201840109
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
T. Kisseleva (2012)
10.1158/1078-0432.CCR-10-1824
Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression
Ming-Heng Wu (2011)
10.1016/j.ccell.2017.10.005
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
V. Kumar (2017)
10.1158/0008-5472.CAN-14-1666
Sonic hedgehog signaling in Basal cell nevus syndrome.
M. Athar (2014)
10.1126/science.1195300
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Matthew Kraman (2010)
This is the first report demonstrating that metabolic reprograming of the tumour stroma inactivates CAFs and suppresses tumour progression
F E Froeling (2011)
10.1158/0008-5472.CAN-13-2259
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.
F. Bruzzese (2014)
10.1186/s12885-015-1241-x
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial
H. Niess (2015)
Carcinoma associated fibroblasts direct tumor progression of initiated human prostatic epithelium
A Olumi (1999)
10.1016/j.ccr.2014.04.005
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
B. Özdemir (2014)
10.1016/j.ccr.2014.03.021
A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.
Shicheng Su (2014)
10.1056/NEJM198612253152606
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
H. Dvorak (1986)
10.1046/J.1523-1747.2003.12035.X
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
M. Huber (2003)
10.12968/chca.2008.5.10.31383
The next generation.
G. Collins (2006)
implication for implantation of metastases
O. Picard (1986)
Clinical and functional significance of loss of caveolin-1 expression in breast cancerassociated fibroblasts
S. A. Simpkins (2012)
a randomised, controlled, open label, phase 3 trial
Zalcman (2016)
10.1371/journal.pmed.0050019
Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
K. Pietras (2008)
10.1002/ijc.23925
Stromal myofibroblasts are drivers of invasive cancer growth
O. De Wever (2008)
10.1016/j.ccr.2014.04.021
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Andrew D. Rhim (2014)
10.1016/j.devcel.2011.07.001
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.
A. Armulik (2011)
10.1200/JCO.2005.03.4082
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
D. Reardon (2006)
10.1016/j.devcel.2008.05.009
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.
Jiaqi Yang (2008)
10.1038/nature10144
Molecular mechanisms and clinical applications of angiogenesis
P. Carmeliet (2011)
This is a comprehensive Review of tumourassociated MSCs as cancer therapeutic targets
wounds that do not heal
Dvorak (1986)
10.1038/ncomms10204
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Jean Albrengues (2015)
10.1038/onc.2014.410
Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer
Cynthia E. Weber (2014)
10.1038/ncb3478
A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion
A. Labernadie (2017)
10.1038/nrd2137
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
B. S. Zhou (2009)
phase II study results
Reardon (2006)
study protocol of a phase I/II clinical trial
Niess (2015)
Targeting fibroblast activation protein inhibits tumor www.nature.com/nrd R e v i e w s stromagenesis and growth in mice
A. M. Santos (2009)
10.1016/j.cell.2011.05.040
Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
J. Goetz (2011)
10.1159/000069863
Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer
R. Hofheinz (2003)
10.1158/0008-5472.CAN-10-1722
Cancer exosomes trigger fibroblast to myofibroblast differentiation.
J. Webber (2010)
10.1073/PNAS.90.3.999
Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue.
D. Lazard (1993)
10.1172/JCI66369
Hepatic stellate cells in liver development, regeneration, and cancer.
C. Yin (2013)
10.1016/j.ejca.2017.08.001
Tumour radiosensitivity is associated with immune activation in solid tumours.
T. Strom (2017)
10.1073/pnas.1109493108
VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization
Joyce T. O’Connell (2011)
10.1016/j.cell.2014.08.007
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
M. Sherman (2014)
10.1038/ncb3228
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Maria-Giuseppina Procopio (2015)
10.1038/nature25501
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S. Mariathasan (2018)
10.1038/nm.3394
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail (2013)
This is the first report that provides precise characterization of CAF heterogeneity in cancer
D Ohlund (2017)
10.1158/0008-5472.CAN-12-1875
STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.
C. Peña (2013)
10.1038/onc.2010.509
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
K. Vuoriluoto (2011)
10.1002/path.4961
Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma
Lijie Ma (2017)
10.1200/JCO.1994.12.6.1193
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
S. Welt (1994)
10.1016/j.jtho.2016.05.025
IL‐6 Secreted from Cancer‐Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial‐Mesenchymal Transition Signaling
Y. Shintani (2016)
10.1080/14753820.2019.1662973
II
revisão da literatura (2019)
10.1038/nature06188
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
A. Karnoub (2007)
10.1158/2326-6066.CIR-13-0027
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
L. Wang (2013)
10.1007/s13402-011-0012-1
Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors
Constantin Jotzu (2011)
AZD9150, a nextgeneration antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
D Hong (2015)
developmental, physiological, and pathological perspectives, problems, and promises
A. Armulik (2011)
10.1038/cddis.2017.225
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
E. H. Cheteh (2017)
10.1038/ncb2756
Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts
F. Calvo (2013)
10.1016/j.ceb.2010.08.015
Dynamic interplay between the collagen scaffold and tumor evolution.
M. Egeblad (2010)
10.1172/JCI15518
Evidence that fibroblasts derive from epithelium during tissue fibrosis.
M. Iwano (2002)
Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts.
M. Stoker (1966)
10.18632/oncotarget.9296
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts
Siham Moatassim-Billah (2016)
10.1038/nature17392
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
A. Kaur (2016)
10.1158/1078-0432.CCR-06-1586
A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors
A. Chiappori (2007)
10.1016/J.CCR.2004.06.010
Molecular characterization of the tumor microenvironment in breast cancer.
M. Allinen (2004)
10.1038/onc.2013.191
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
G. Comito (2014)
10.1038/nrclinonc.2018.8
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
D. Johnson (2018)
10.1158/1078-0432.CCR-07-5211
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
E. Ostermann (2008)
10.1073/pnas.1320318110
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
Christine Feig (2013)
10.1016/j.ccr.2012.01.007
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
P. Provenzano (2012)
tissue is related to poor outcome in prostate cancer patients
J. Huelsken (2009)
Targeting fibroblast activation protein inhibits tumor www.nature.com/nrd stromagenesis and growth in mice
A M Santos (2009)
10.1038/nm.4082
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression
Hanane Laklai (2016)
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
G. Ayala (2003)
10.1016/S1359-6446(98)01222-7
Emerging therapeutic targets
D. Gurwitz (1998)
implications for tumor development and progression
M. P. Shekhar (2001)
This study provides the first evidence for the role of CAFs in primary tumour stroma in determining specific organ-tropic metastasis of primary cancer cells
10.1038/nature04186
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
R. Kaplan (2005)
10.1186/1756-9966-29-80
Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction
Mingzhu Huang (2010)
10.1038/mt.2013.110
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Sunitha Kakarla (2013)
10.1158/0008-5472.CAN-10-0785
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.
E. Giannoni (2010)
10.1158/0008-5472.CAN-08-0943
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.
Pravin J Mishra (2008)
10.1158/1538-7445.AM2013-1287
Abstract 1287: Epigenetic deregulation of breast cancer is associated with DNA Repair Capacity.
J. Matta (2013)
10.1016/j.ccr.2009.12.041
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.
Neta Erez (2010)



This paper is referenced by
10.1016/j.trecan.2019.02.005
Inhibiting Tumor Fibrosis and Actomyosin through GPCR activation.
Lawrence J. Dooling (2019)
10.3390/cancers12102861
Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
P. Hurtado (2020)
10.1016/j.semnephrol.2020.01.012
The Role of Tubule-Interstitial Crosstalk in Renal Injury and Recovery.
I. Schiessl (2020)
10.1016/j.trecan.2019.09.009
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
E. D. De Jaeghere (2019)
10.3389/fphar.2020.01009
Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses
H. Huang (2020)
10.1007/112_2020_23
How Reciprocal Interactions Between the Tumor Microenvironment and Ion Transport Proteins Drive Cancer Progression.
Line O Elingaard-Larsen (2020)
10.1016/j.bbcan.2019.06.003
Fibroblasts in cancer: Defining target structures for therapeutic intervention.
M. Boesch (2019)
10.3389/fimmu.2019.01720
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
V. Audrito (2019)
10.3389/fimmu.2020.531491
IDO Expression in Cancer: Different Compartment, Different Functionality?
Annabel Meireson (2020)
10.1016/j.ctro.2020.04.001
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
M. Ansems (2020)
10.3390/biomedicines8110474
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
Anne Everts (2020)
10.1007/978-3-030-34025-4_3
Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.
Andreia Pereira-Nunes (2020)
10.1007/978-981-13-6657-4_18
Practical Application of Periostin as a Biomarker for Pathological Conditions.
I. Kii (2019)
10.1007/s00432-020-03489-z
Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment
Tongtong Wei (2021)
10.1038/s41467-020-17083-x
Spatial domain analysis predicts risk of colorectal cancer recurrence and infers associated tumor microenvironment networks
Shikhar Uttam (2020)
10.3390/cancers11101608
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
Mohamed A. Abd El Aziz (2019)
10.1152/physrev.00048.2019
DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.
G. Biffi (2020)
10.1002/med.21765
Understanding the tumor microenvironment for effective immunotherapy.
Habib Sadeghi Rad (2020)
10.1142/s1088424620300098
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization — a Thomas Dougherty Award for Excellence in PDT paper
P. D. Silva (2020)
10.1186/s13058-020-01289-4
Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients
M. M. Al-Ansari (2020)
10.1093/gastro/goaa045
The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
Yun-qiang Tang (2020)
10.3389/fcell.2020.00630
Fibroblast Reprogramming in Gastrointestinal Cancer
Maria-Theodora Melissari (2020)
10.3390/cells9092143
miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts
Giulia Cosentino (2020)
10.3389/fcell.2020.00260
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
J. Ma (2020)
10.3390/jcm9092967
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
A. Macpherson (2020)
10.3779/j.issn.1009-3419.2020.102.16
[Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
Chongbiao Huang (2020)
10.1208/s12248-019-0333-y
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
Quoc-Viet Le (2019)
10.3390/cells9040863
Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences
Kristin L Eckel-Mahan (2020)
10.1007/978-3-030-35727-6_7
The Multifaceted Effects of Autophagy on the Tumor Microenvironment.
Rui Kang (2020)
10.1016/j.coemr.2020.01.004
Contributions of carcinoma-associated fibroblasts to the prostate cancer microenvironment
Renee E Vickman (2020)
10.3390/cancers11121855
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
L. Salvioni (2019)
10.1074/jbc.RA120.013805
Survivin in breast cancer–derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis
Kangdi Li (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar